These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 34229305)
1. Cerebral blood flow response rate to task-activation using a novel method can discriminate cognitive impairment from healthy aging. Beishon L; Panerai RB; Robinson TG; Haunton VJ Physiol Meas; 2021 Jul; 42(7):. PubMed ID: 34229305 [No Abstract] [Full Text] [Related]
2. An objective method to identify non-responders in neurovascular coupling testing. Beishon LC; Williams CA; Intharakham K; Batterham AP; Barnes SC; Haunton VJ; Robinson TG; Panerai RB J Neurosci Methods; 2020 Jul; 341():108779. PubMed ID: 32417533 [TBL] [Abstract][Full Text] [Related]
3. The Interaction of Dynamic Cerebral Autoregulation and Neurovascular Coupling in Cognitive Impairment. Beishon LC; Intharakham K; Haunton VJ; Robinson TG; Panerai RB Curr Alzheimer Res; 2021; 18(14):1067-1076. PubMed ID: 35026972 [TBL] [Abstract][Full Text] [Related]
4. The Assessment of Cerebrovascular Response to a Language Task from the Addenbrooke's Cognitive Examination in Cognitive Impairment: A Feasibility Functional Transcranial Doppler Ultrasonography Study. Beishon LC; Panerai RB; Robinson TG; Subramaniam H; Haunton VJ J Alzheimers Dis Rep; 2018 Sep; 2(1):153-164. PubMed ID: 30480258 [TBL] [Abstract][Full Text] [Related]
5. The assessment of neurovascular coupling with the Addenbrooke's Cognitive Examination: a functional transcranial Doppler ultrasonographic study. Beishon LC; Williams CAL; Panerai RB; Robinson TG; Haunton VJ J Neurophysiol; 2018 Mar; 119(3):1084-1094. PubMed ID: 29187557 [TBL] [Abstract][Full Text] [Related]
6. The Effects of Healthy Ageing on Cerebral Blood Flow Responses to Cognitive Testing. Beishon L; Minhas JS; Patrick K; Shanmugam I; Williams CAL; Panerai RB; Robinson TG; Haunton VJ Curr Aging Sci; 2019; 11(4):226-235. PubMed ID: 30706798 [TBL] [Abstract][Full Text] [Related]
7. Principal component analysis to identify the major contributors to task-activated neurovascular responses. Ball J; Panerai RB; Williams CAL; Beishon L Cereb Circ Cogn Behav; 2022; 3():100039. PubMed ID: 36324414 [TBL] [Abstract][Full Text] [Related]
8. Accuracy of verbal fluency tests in the discrimination of mild cognitive impairment and probable Alzheimer's disease in older Spanish monolingual individuals. García-Herranz S; Díaz-Mardomingo MC; Venero C; Peraita H Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2020 Nov; 27(6):826-840. PubMed ID: 31822214 [TBL] [Abstract][Full Text] [Related]
9. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study. Yoon JH; Kim M; Moon SY; Yong SW; Hong JM J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880 [TBL] [Abstract][Full Text] [Related]
10. Reproducibility of task activation using the Addenbrooke's cognitive examination in healthy controls: A functional Transcranial Doppler ultrasonography study. Beishon L; Williams CAL; Panerai RB; Robinson TG; Haunton VJ J Neurosci Methods; 2017 Nov; 291():131-140. PubMed ID: 28827165 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Mild Cognitive Impairment Using Cognitive Tasks: A Functional Near-Infrared Spectroscopy Study. Yoo SH; Woo SW; Shin MJ; Yoon JA; Shin YI; Hong KS Curr Alzheimer Res; 2020; 17(13):1145-1160. PubMed ID: 33583382 [TBL] [Abstract][Full Text] [Related]
12. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities. Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory. Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659 [TBL] [Abstract][Full Text] [Related]
14. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease? Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850 [TBL] [Abstract][Full Text] [Related]
15. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia. Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593 [TBL] [Abstract][Full Text] [Related]
16. The Diagnostic and Prognostic Value of a Dual-Tasking Paradigm in a Memory Clinic. Nielsen MS; Simonsen AH; Siersma V; Hasselbalch SG; Hoegh P J Alzheimers Dis; 2018; 61(3):1189-1199. PubMed ID: 29278887 [TBL] [Abstract][Full Text] [Related]
17. Multiple category verbal fluency in mild cognitive impairment and correlation with CSF biomarkers for Alzheimer's disease. Mirandez RM; Aprahamian I; Talib LL; Forlenza OV; Radanovic M Int Psychogeriatr; 2017 Jun; 29(6):949-958. PubMed ID: 28179036 [TBL] [Abstract][Full Text] [Related]
18. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults. Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ; BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644 [TBL] [Abstract][Full Text] [Related]
19. Distinguishing mild cognitive impairment from healthy aging and Alzheimer's Disease: The contribution of the INECO Frontal Screening (IFS). Moreira HS; Costa AS; Machado Á; Castro SL; Lima CF; Vicente SG PLoS One; 2019; 14(9):e0221873. PubMed ID: 31504056 [TBL] [Abstract][Full Text] [Related]
20. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia. Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]